Congress After a Quiet Summer, Congress Starts Probe into MS Drugs Thomas Sullivan Aug 30, 2017 0 Congress has recently taken a few months off from constantly barraging the pharmaceutical industry with daily probes and negative…
Life Science Compliance Update A Murky Future for Off-label Promotion: States vs. FDA – Arizona to… Thomas Sullivan Aug 30, 2017 0 Arizona was the first state to bite the bullet and allow pharmaceutical companies to communicate off-label uses of their drugs to…
